NSE: INDOCO
INDOCO REMEDIES LTD.
Price history
+12.30% over 3M
Performance
52-week range
Position in day range
INDOCO stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹236.77
RSI (14)
54
Neutral momentum
Volatility (ATR)
6.52%
High
Close streak
5d down
Volume vs 20d avg
5.08x
Unusual activity
From 52W high
-23.46%
Up from 52W low
+56.76%
Green days (20)
11/20
Monthly seasonality
Average monthly move for INDOCO across the available price history.
Key statistics
Open
234.94
Day high
269.9
Day low
229
Prev close
254.25
Volume
60.15 L
Avg vol (20d)
11.83 L
52W high
332.2
52W low
162.19
INDOCO quarterly results
All INDOCO results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹466 cr
+8.2% YoY
Net profit
₹64.99 cr
+281.6% YoY
Operating profit
₹6.49 cr
+153.3% YoY
EPS
₹7.09
+279.9% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹466 cr | ₹6.49 cr | ₹64.99 cr | 1.4% | 13.9% | ₹7.09 | +281.6% | +400.3% |
| Q4 FY262026-03-31 | ₹456 cr | ₹17.22 cr | -₹21.64 cr | 3.8% | -4.7% | ₹-2.57 | — | +27.4% |
| Q3 FY262025-12-31 | ₹434 cr | -₹0.5 cr | -₹29.79 cr | -0.1% | -6.9% | ₹-3.20 | — | -275.7% |
| Q2 FY262025-09-30 | ₹472 cr | ₹10.8 cr | -₹7.93 cr | 2.3% | -1.7% | ₹-1.00 | — | +77.8% |
| Q1 FY262025-06-30 | ₹431 cr | -₹12.17 cr | -₹35.79 cr | -2.8% | -8.3% | ₹-3.94 | — | — |
| TTM (last 4 quarters) | ₹1,828 cr | ₹34.01 cr | ₹5.63 cr | 1.9% | 0.3% | ₹0.32 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.